Glaxosmithkline Teams Up With Biotech Company

GlaxoSmithKline signed a potential $1 billion deal with U.S. biotech company Concert Pharmaceuticals to develop drugs that use deuterium, a chemical that could improve how some medicines work. The collaboration will beef up GlaxoSmithKline's pipeline of early stage drugs.

BING NEWS:
  • GSK teams with Relation to advance fibrotic, osteoarthritis therapies
    As part of the deal, GSK will pay Relation $45 million in upfront payments, which includes an equity investment of $15 million.
    12/10/2024 - 3:21 am | View Link
  • GSK pens $45M Relation-ship with AI biotech to identify fibrotic, osteoarthritis targets
    GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for fibrotic diseases and osteoarthritis. | GSK has handed over $45 million upfront ...
    12/9/2024 - 7:59 pm | View Link
  • GSK taps Rgenta to develop new RNA-targeting treatments, offering up to $500M per target
    Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a pipeline of oral RNA-targeting small molecules. | Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a ...
    12/3/2024 - 11:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News